|Day Low/High||30.40 / 30.76|
|52 Wk Low/High||19.25 / 33.06|
The most recent short interest data has been released for the 03/15/2017 settlement date, which shows a 877,014 share increase in total short interest for Globus Medical Inc , to 9,613,206, an increase of 10.04% since 02/28/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Investors in Globus Medical Inc saw new options begin trading this week, for the September 15th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 234 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
Excelsius GPS™ - Robotic Trajectory Guidance and Navigation for Surgery
The most recent short interest data has been released for the 11/15/2016 settlement date, which shows a 990,027 share decrease in total short interest for Globus Medical Inc , to 6,671,333, a decrease of 12.92% since 10/31/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Here are Wednesday's top research calls, including upgrades for F5 Networks, U.S. Steel, Lockheed Martin and Sysco, and downgrades for GoPro, Kansas City Southern, Globus and Constellation Brands.
INDEPENDENCE MIS™ enhances the ALIF surgical technique by offering fewer procedural steps and a less invasive surgical corridor than traditional integrated spacers
QUARTEX™ Occipito-Cervico-Thoracic (OCT) Stabilization System is a threaded screw and rod platform offering true thoracic pedicle screws with diameters up to 5.5 mm, allowing surgeons to take full advantage of varying spinal anatomy.
Investors in Globus Medical Inc saw new options become available today, for the November 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GMED options chain for the new November 18th contracts and identified one put and one call contract of particular interest.
Trade-Ideas LLC identified Globus Medical (GMED) as a "dead cat bounce" (down big yesterday but up big today) candidate
Here are Wednesday's top research calls, including upgrades for Coach and Alaska Air, and downgrades for Southwest Airlines and Twitter.
These five technical setups are showing solid upside potential right now.
The health care sector is booming, but many stocks are overvalued. We pinpoint the best buys now in the medical device niche.
These medical device makers could be acquisition targets (and one buyer) following Zimmer Biomet's takeout of LDR Holding. Their charts are also buys, says technical chartist Bruce Kamich.
The $1 billion transaction could inspire other medical device companies and private equity firms to bend over backwards for spinal device assets.
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Globus Medical Inc , where a total volume of 3,046 contracts has been traded thus far today, a contract volume which is representative of approximately 304,600 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 54.1% of GMED's average daily trading volume over the past month, of 563,450 shares.
The hefty premium Zimmer Biomet is paying in the $1 billion deal for the spine company suggests the target's management followed a competitive process.
Globus Medical (GMED) coverage was started with an ‘equal weight’ rating and $26 price target at Barclays.